Crossmark

Proton Therapy in Non-small Cell Lung Cancer

Crossref DOI link: https://doi.org/10.1007/s11864-018-0588-z

Published Online: 2018-11-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mesko, Shane

Gomez, Daniel
License Information

Text and Data Mining valid from 2018-11-27
More Information

Article History

First Online: 27 November 2018

Compliance with Ethical Standards

:

: Shane Mesko has received compensation from Oscar Healthcare for service as a consultant.Daniel Gomez has received research funding from Merck, Bristol-Myers Squibb, and AstraZeneca, and has received compensation from Varian, Driver, US Oncology, and RefleXion for service as a consultant.

: This article does not contain any studies with human or animal subjects performed by any of the authors.